Ainsley GaddisTransfer Pricing Controversy Leader at GE HEALTHCARE
Ainsley is the Global Transfer Pricing Controversy Leader at GE Healthcare, a leading global medical technology and life sciences company providing a broad portfolio of products solutions and services in the diagnosis, treatment and monitoring of patients. Ainsley has more than 15 years of experience in international tax and transfer pricing, both in public accounting and in-house across several industries. Ainsley is a CPA and began her career in International Tax Consulting with Ernst & Young. From there she transitioned to industry with transfer pricing roles at McDonald’s Corporation, BP and Mead Johnson Nutrition (acquired by Reckitt-Benckiser).
In her current role at GE Healthcare, Ainsley is responsible for managing global transfer pricing risk, including transfer pricing documentation, global transfer pricing audit defense and financial risk analysis.